Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes.

Abstract:

:Mesenchymal stromal cells (MSCs) suppress T cell responses through mechanisms not completely understood. Adenosine is a strong immunosuppressant that acts mainly through its receptor A(2a) (ADORA2A). Extracellular adenosine levels are a net result of its production (mediated by CD39 and CD73), and of its conversion into inosine by Adenosine Deaminase (ADA). Here we investigated the involvement of ADO in the immunomodulation promoted by MSCs. Human T lymphocytes were activated and cultured with or without MSCs. Compared to lymphocytes cultured without MSCs, co-cultured lymphocytes were suppressed and expressed higher levels of ADORA2A and lower levels of ADA. In co-cultures, the percentage of MSCs expressing CD39, and of T lymphocytes expressing CD73, increased significantly and adenosine levels were higher. Incubation of MSCs with media conditioned by activated T lymphocytes induced the production of adenosine to levels similar to those observed in co-cultures, indicating that adenosine production was mainly derived from MSCs. Finally, blocking ADORA2A signaling raised lymphocyte proliferation significantly. Our results suggest that some of the immunomodulatory properties of MSCs may, in part, be mediated through the modulation of components related to adenosine signaling. These findings may open new avenues for the development of new treatments for GVHD and other inflammatory diseases.

journal_name

Stem Cell Res

journal_title

Stem cell research

authors

Saldanha-Araujo F,Ferreira FI,Palma PV,Araujo AG,Queiroz RH,Covas DT,Zago MA,Panepucci RA

doi

10.1016/j.scr.2011.04.001

subject

Has Abstract

pub_date

2011-07-01 00:00:00

pages

66-74

issue

1

eissn

1873-5061

issn

1876-7753

pii

S1873-5061(11)00031-6

journal_volume

7

pub_type

杂志文章
  • Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.

    abstract::Neural stem cells (NSCs) have been considered as potential therapy in Alzheimer's disease (AD) but their use is hampered by the poor survival of grafted cells. Supply of neurotrophic factors to the grafted cells has been proposed as a way to augment survival of the stem cells. In this context, we investigated the util...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2015.04.008

    authors: Rockenstein E,Desplats P,Ubhi K,Mante M,Florio J,Adame A,Winter S,Brandstaetter H,Meier D,Masliah E

    更新日期:2015-07-01 00:00:00

  • Derivation and characterization of the human embryonic stem cell line CR-4: Differentiation to human retinal pigment epithelial cells.

    abstract::The CR-4 human embryonic stem cell line was derived from the inner cell mass of a developing blastocyst. This cell line has been adapted to grow in feeder-free conditions and is especially well-suited for differentiation to retinal pigment epithelium. The line demonstrates a normal human 46,XX female karyotype. Plurip...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2016.12.005

    authors: Mazzilli JL,Domozhirov AY,Mueller-Ortiz SL,Garcia CA,Wetsel RA,Zsigmond EM

    更新日期:2017-01-01 00:00:00

  • Transgenic human ES and iPS reporter cell lines for identification and selection of pluripotent stem cells in vitro.

    abstract::Optimization of pluripotent stem cell expansion and differentiation is facilitated by biological tools that permit non-invasive and dynamic monitoring of pluripotency, and the ability to select for an undifferentiated input cell population. Here we report on the generation and characterisation of clonal human embryoni...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2014.05.006

    authors: Ovchinnikov DA,Titmarsh DM,Fortuna PR,Hidalgo A,Alharbi S,Whitworth DJ,Cooper-White JJ,Wolvetang EJ

    更新日期:2014-09-01 00:00:00

  • An integration-free iPSC line SDQLCHi025-A from a girl with multiminicore disease carrying compound heterozygote mutations in RYR1 gene.

    abstract::Peripheral blood mononuclear cells for reprogramming in this work were donated by a girl with clinically and genetically diagnosed multiminicore disease harboring compound heterozygote mutations of RYR1 gene. Induced pluripotent stem cells (iPSCs) were obtained by non-integrating episomal vectors containing OCT4, SOX2...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2020.101775

    authors: Zhang H,Ma Y,Lv Y,Wan Y,Zhao Q,Gai Z,Liu Y

    更新日期:2020-05-01 00:00:00

  • Generation of an isogenic, gene-corrected iPSC line from a pre-symptomatic 28-year-old woman with an R406W mutation in the microtubule associated protein tau (MAPT) gene.

    abstract::Frontotemporal dementia with parkinsonism linked to chromosome 17q21.2 (FTDP-17) is an autosomal-dominant neurodegenerative disorder. Mutations in the MAPT (microtubule-associated protein tau) gene can cause FTDP-17, but the underlying pathomechanisms of the disease are still unknown. Induced pluripotent stem cells (i...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2016.09.024

    authors: Nimsanor N,Poulsen U,Rasmussen MA,Clausen C,Mau-Holzmann UA,Nielsen JE,Nielsen TT,Hyttel P,Holst B,Schmid B

    更新日期:2016-11-01 00:00:00

  • A computational strategy for predicting lineage specifiers in stem cell subpopulations.

    abstract::Stem cell differentiation is a complex biological event. Our understanding of this process is partly hampered by the co-existence of different cell subpopulations within a given population, which are characterized by different gene expression states driven by different underlying transcriptional regulatory networks (T...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2015.08.006

    authors: Okawa S,del Sol A

    更新日期:2015-09-01 00:00:00

  • Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing.

    abstract::To develop a disease model for the human 'brittle bone' disease, osteogenesis imperfecta, we have used gene editing to produce a facsimile of the patient heterozygous COL1A1 mutation in an established control iPSC line. The gene-edited line had a normal karyotype, expressed pluripotency markers and differentiated into...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2019.101449

    authors: Hosseini Far H,Patria YN,Motazedian A,Elefanty AG,Stanley EG,Lamandé SR,Bateman JF

    更新日期:2019-05-01 00:00:00

  • Bone marrow cells play only a very minor role in chronic liver regeneration induced by a choline-deficient, ethionine-supplemented diet.

    abstract::Liver progenitor (oval) cells have enormous potential in the treatment of patients with liver disease using a cell therapy approach, but their use is limited by their scarcity and the number of donor livers from which they can be derived. Bone marrow may be a suitable source. Previously the derivation of oval cells fr...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2008.05.004

    authors: Tonkin JN,Knight B,Curtis D,Abraham LJ,Yeoh GC

    更新日期:2008-09-01 00:00:00

  • Cell surface markers for the identification and study of human naive pluripotent stem cells.

    abstract::Characterisation of mouse pluripotent stem cells has revealed two distinct pluripotent states, naive and primed, that maintain characteristics of the pre and post implanted epiblast respectively. Recent studies have developed several culture systems that seek to recapitulate the naive phenomenon in human pluripotent s...

    journal_title:Stem cell research

    pub_type: 杂志文章,评审

    doi:10.1016/j.scr.2017.11.017

    authors: Trusler O,Huang Z,Goodwin J,Laslett AL

    更新日期:2018-01-01 00:00:00

  • CD133+ cells derived from skeletal muscles of Duchenne muscular dystrophy patients have a compromised myogenic and muscle regenerative capability.

    abstract::Cell-mediated gene therapy is a possible means to treat muscular dystrophies like Duchenne muscular dystrophy. Autologous patient stem cells can be genetically-corrected and transplanted back into the patient, without causing immunorejection problems. Regenerated muscle fibres derived from these cells will express the...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2018.05.004

    authors: Meng J,Muntoni F,Morgan J

    更新日期:2018-07-01 00:00:00

  • Generation of FOS gene knockout lines from a human embryonic stem cell line using CRISPR/Cas9.

    abstract::FOS is component of the AP-1 complex and has been reported to be involved in many cellular functions, including cell proliferation, differentiation, survival, angiogenesis, hematopoiesis and cancer progress. To further understand the exact role of FOS in these processes, here we created two FOS knockout human embryoni...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2019.101479

    authors: Li C,Wang Q,Peng Z,Lin Y,Liu H,Yang X,Li S,Liu X,Chen J

    更新日期:2019-08-01 00:00:00

  • Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.

    abstract::Spinocerebellar ataxia type 3 (SCA3) is a dominantly inherited neurodegenerative disease caused by a CAG-repeat expanding mutation in ATXN3. We generated induced pluripotent stem cells (iPSCs) from a SCA3 patient by electroporation of dermal fibroblasts with episomal plasmids encoding L-MYC, LIN28, SOX2, KLF4, OCT4 an...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2016.02.040

    authors: Hansen SK,Borland H,Hasholt LF,Tümer Z,Nielsen JE,Rasmussen MA,Nielsen TT,Stummann TC,Fog K,Hyttel P

    更新日期:2016-05-01 00:00:00

  • Generation of a transgene-free induced pluripotent stem cells line (UNIPDi002-A) from oral mucosa epithelial stem cells carrying the R304Q mutation in TP63 gene.

    abstract::Transgene free UNIPDi002-A-human induced pluripotent stem cell (hiPSC) line was generated by Sendai Virus Vectors reprogramming from human oral mucosal epithelial stem cells (hOMESCs) of a patient affected by ectrodactyly-ectodermal dysplasia-clefting (EEC)-syndrome, carrying a mutation in exon 8 of the TP63 gene (R30...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2018.02.006

    authors: Trevisan M,Barbaro V,Riccetti S,Masi G,Barzon L,Nespeca P,Alvisi G,Di Iorio E,Palù G

    更新日期:2018-04-01 00:00:00

  • Generation of four postmortem dura-derived iPS cell lines from four control individuals with genotypic and brain-region-specific transcriptomic data available through the BrainSEQ consortium.

    abstract::In this study, we established induced pluripotent stem (iPS) cell lines from postmortem dura-derived fibroblasts of four control individuals with low polygenic risk score for psychiatric disorders including schizophrenia and bipolar disorder. The fibroblasts were reprogrammed into iPS cells using episomal vectors carr...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2020.101806

    authors: Sawada T,Benjamin KJM,Brandtjen AC,Tietze E,Allen SJ,Paquola ACM,Kleinman JE,Hyde TM,Erwin JA

    更新日期:2020-07-01 00:00:00

  • Generation of GADD45A gene knockout human embryonic stem cell line using CRISPR/Cas9.

    abstract::GADD45A is a DNA damage and stressful growth arrest inducible protein, also it is shown to a be tumor suppressor gene and a chromatin relaxer associated with opening chromatin during the somatic reprogramming. However, its role in human embryonic stem cells and human embryonic stem cell modeled development has been me...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2020.102090

    authors: Li J,Li Y,Zhan XY,Ran X,Tse HF,Dang S,Nie Y,Huang K

    更新日期:2020-12-01 00:00:00

  • Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect.

    abstract::Angelman syndrome (AS) is a neurodevelopmental disorder with leading symptoms of happy demeanor, intellectual disability, ataxia and seizures. AS can be caused by genetic and epigenetic aberrations, resulting in the absence of functional UBE3A protein in the brain. UBE3A is an imprinted gene, which is, in neurons of t...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2018.09.015

    authors: Neureiter A,Brändl B,Hiber M,Tandon R,Müller FJ,Steenpass L

    更新日期:2018-12-01 00:00:00

  • Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene.

    abstract::BRCA1 germline mutation confers hereditary predisposition for breast and ovarian cancer. To understand the physiopathology of mammary and ovarian epithelial cancer transformation, and to identify early driver molecular events, we have generated an iPSC line from a patient carrying a germline exon 17 deletion in BRCA1 ...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2017.09.003

    authors: Griscelli F,Oudrhiri N,Feraud O,Divers D,Portier L,Turhan AG,Bennaceur Griscelli A

    更新日期:2017-10-01 00:00:00

  • Generation of a NKX2.1 - p63 double transgenic knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-4).

    abstract::Tumor protein p63 (p63) encodes for a transcription factor of the p53 family and is a marker for respiratory basal cells. Based on a NKX2.1 knock-in reporter cell line from human induced pluripotent stem cells (hiPSCs) (MHHi06-A-2) we established a NKX2.1/p63 double transgenic knock-in reporter cell line using TALEN t...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2019.101659

    authors: Drick N,Sahabian A,Pongpamorn P,Merkert S,Göhring G,Welte T,Martin U,Olmer R

    更新日期:2020-01-01 00:00:00

  • Generation of non-transgenic iPS cells from human cord blood CD34+ cells under animal component-free conditions.

    abstract::Recently, many hurdles and limitations for production of clinically applicable iPSC derivatives have been overcome. Transgene-free iPSCs can be efficiently derived from easily accessible cell sources such as blood. Here we describe the generation of transgene-free hiPS cells from cord blood derived CD34+ cells, reprog...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2017.03.022

    authors: Haase A,Göhring G,Martin U

    更新日期:2017-05-01 00:00:00

  • An induced pluripotent stem cell line (TRNDi009-C) from a Niemann-Pick disease type A patient carrying a heterozygous p.L302P (c.905 T>C) mutation in the SMPD1 gene.

    abstract::Niemann-Pick disease type A (NPA) is a rare autosomal recessive lysosomal storage disease caused by mutations in the SMPD1 gene, which encodes for the protein acid sphingomyelinase. A human induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts of a 21-fetal-week-old female patient with NPA th...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2019.101461

    authors: Baskfield A,Li R,Beers J,Zou J,Liu C,Zheng W

    更新日期:2019-07-01 00:00:00

  • The contribution of human/non-human animal chimeras to stem cell research.

    abstract::Chimeric animals are made up of cells from two separate zygotes. Human/non-human animal chimeras have been used for a number of research purposes, including human disease modeling. Pluripotent stem cell (PSC) research has relied upon the chimera approach to examine the developmental potential of stem cells, to determi...

    journal_title:Stem cell research

    pub_type: 杂志文章,评审

    doi:10.1016/j.scr.2017.09.005

    authors: Levine S,Grabel L

    更新日期:2017-10-01 00:00:00

  • Murine transgenic iPS cell line for monitoring and selection of cardiomyocytes.

    abstract::We report here a transgenic murine induced pluripotent stem cell (iPSC) line expressing puromycin N-acetyltransferase (PAC) and enhanced green fluorescent protein (EGFP) under the control of α-myosin heavy chain promoter. This transgenic cell line reproducibly differentiates into EGFP-expressing cardiomyocytes (CMs) w...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2016.07.007

    authors: Fatima A,Xu G,Nguemo F,Kuzmenkin A,Burkert K,Hescheler J,Šarić T

    更新日期:2016-09-01 00:00:00

  • A quantitative hematopoietic stem cell reconstitution protocol: Accounting for recipient variability, tissue distribution and cell half-lives.

    abstract::Hematopoietic stem and progenitor cell (HSPC) transplantation is the paradigm for stem cell therapies. The protocol described here enables quantitative assessment of the body-wide HSPC reconstitution of different mature hematopoietic cells in mice based on their presence in circulating blood. The method determines don...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2020.102145

    authors: Rajendiran S,Boyer SW,Forsberg EC

    更新日期:2020-12-29 00:00:00

  • Generation of KCL034 clinical grade human embryonic stem cell line.

    abstract::The KCL034 human embryonic stem cell line was derived from a normal healthy blastocyst donated for research. The ICM was isolated using laser microsurgery and plated on γ-irradiated human foreskin fibroblasts. Both the derivation and cell line propagation were performed in an animal product-free environment and under ...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2015.12.034

    authors: Devito L,Jacquet L,Petrova A,Miere C,Wood V,Kadeva N,Cornwell G,Codognotto S,Stephenson E,Ilic D

    更新日期:2016-01-01 00:00:00

  • Prostate progenitor cells proliferate in response to castration.

    abstract::Androgen-deprivation is a mainstay of therapy for advanced prostate cancer but tumor regression is usually incomplete and temporary because of androgen-independent cells in the tumor. It has been speculated that these tumor cells resemble the stem/progenitor cells of the normal prostate. The purpose of this study was ...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2014.04.005

    authors: Shi X,Gipp J,Dries M,Bushman W

    更新日期:2014-07-01 00:00:00

  • Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.

    abstract::CHCHD2 mutation has been reported as a potential cause of a rare form of familial Parkinson's disease. Recently, a novel CHCHD2 mutation was identified in a family with Parkinson's disease. The dermal fibroblasts of the patient were obtained and successfully transformed into induced pluripotent stem cells(iPSCs), empl...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2018.08.011

    authors: Wang Y,Wang Z,Sun H,Mao C,Yang J,Liu Y,Liu H,Zhang S,Zhang J,Xu Y,Shi C

    更新日期:2018-10-01 00:00:00

  • Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome.

    abstract::Urine resource cells were collected from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome (MEN1) for generating iPS cells with episomal plasmids. Two stable iPSC lines with free of episomal plasmid were established. The patient has a heterozygous G>T mutation on the exon 9 of Men1 gene that was con...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2016.12.002

    authors: Guo D,Wu F,Liu H,Gao G,Kou S,Yang F,Abbas N,Zhou T,Cai X,Zhang H,Qin D,Li J,Xu K,Li YX

    更新日期:2017-01-01 00:00:00

  • Generation of human iPSC line GRX-MCiPS4F-A2 from adult peripheral blood mononuclear cells (PBMCs) with Spanish genetic background.

    abstract::We have generated iPSCs from peripheral blood mononuclear cells (PBMCs) of a healthy man using heat sensitive and non-integrative Sendai virus containing Sox2, Oct3/4, c-Myc and Klf4. Human GRX-MCiPS4F-A2 cell line was established and characterized through this study. ...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2015.07.002

    authors: Cabrera S,Ji AR,Frejo L,Ramos-Mejia V,Romero T,Real P,Lopez-Escamez JA

    更新日期:2015-09-01 00:00:00

  • Generation of an induced pluripotent stem cell line (CHFUi001-A) from an osteogenesis imperfecta patient with COL1A2 mutation.

    abstract::Osteogenesis Imperfecta (OI) is a rare autosomal dominant metabolic disorder caused by heterozygous mutations in the COL1A1 or COL1A2 genes, which encode the pro-α1(I) and pro-α2(I) chains of type I procollagen, respectively. A human induced pluripotent stem cell (iPSC) line, termed as CHFUi001-A, was generated from p...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2020.101907

    authors: Zheng Z,Lu W,Pei Z,Chen J,Yang T,Luo F

    更新日期:2020-07-05 00:00:00

  • Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.

    abstract::We have established the patient-specific induced pluripotent stem (iPS) cell line CSUASOi004-A by using peripheral blood mononuclear cells (PBMCs) of a retinitis pigmentosa (RP) patient with a PRPF6 gene mutation (c.G2699A:p.R900H). CSUASOi004-A was established by a non-integrative method with four episomal plasmids c...

    journal_title:Stem cell research

    pub_type: 杂志文章

    doi:10.1016/j.scr.2020.101793

    authors: Zhou Y,Jing Y,Mao S,Liu J,Cui Z,Wang Y,Chen J,Chan HF,Tang S,Chen J

    更新日期:2020-05-01 00:00:00